FDA to review Pfizer rheumatoid arthritis drug
Links shared publicly online about this topic.
- 0total visits
FDA to review Pfizer rheumatoid arthritis drug
View full resource at health.yahoo.net
Tags: Arthritis, Arthritis Medication, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Drug, FDA, Pfizer
Most Recently Shared on December 21, 2011 at 3:11 pm By:
FDA to review Pfizer rheumatoid arthritis drug http://t.co/Vtflk3FD
UPDATE 1-Pfizer says its drug is best hope for Alzheimer's - Yahoo! Finance UK
uk.finance.yahoo.com — “Read 'UPDATE 1-Pfizer says its drug is best hope for Alzheimer's' on Yahoo! Finance UK. * Says prior trials suggest edge over Lilly Alzheimer's drug * Says Prevnar 13 pneumonia data expected by 2013 * Expects FDA panel to review arthritis drug (Adds quotes from research chief, details on ...” View full resource at uk.finance.yahoo.com
Most Recently Shared on February 14, 2012 at 7:37 pm By:
UPDATE 1-Pfizer says its drug is best hope for Alzheimer's: * Says prior trials suggest edge over Lilly Alzheime... http://t.co/I53zjiUn
FDA to Review Pfizer Inc Rheumatoid Arthritis Drug
biospace.com — “NEW YORK, Dec 20, 2011 -- Pfizer Inc. /quotes/zigman/238207/quotes/nls/pfe PFE +1.04% announced today that the U.S. Food and Drug Administration has” View full resource at biospace.com
Most Recently Shared on December 24, 2011 at 6:33 pm By:
FDA to Review Pfizer Inc Rheumatoid Arthritis Drug http://t.co/FGnesrQI
FDA accepts application for Pfizer arthritis drug - seattlepi.com
seattlepi.com — “NEW YORK (AP) — Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.” View full resource at seattlepi.com
Most Recently Shared on December 21, 2011 at 3:12 am By:
Dr OP Garg Rheumatologist, Physician, Doctor, and Internist
Dear friends, New hope for RA patients especially those not responding to the presently available drugs. New drug... http://t.co/K8zAKvf4
Pfizer: FDA, other countries reviewing application for new type of rheumatoid arthritis drug - The Washington Post
washingtonpost.com — “NEW YORK — Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.” View full resource at washingtonpost.com
Most Recently Shared on December 20, 2011 at 9:01 pm By:
Pfizer: FDA, other countries reviewing application for new type of rheumatoid arthritis drug: NEW YORK — Drugmak... http://t.co/b0OypJhA
FDA accepts application for Pfizer arthritis drug - WSJ.com
online.wsj.com — “NEW YORK — Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.” View full resource at online.wsj.com
Most Recently Shared on December 20, 2011 at 8:51 pm By:
FDA accepts application for Pfizer arthritis drug http://t.co/4VTR5V2W
FDA accepts application for Pfizer arthritis drug - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.The FDA says it expects ...” View full resource at finance.yahoo.com
Most Recently Shared on December 20, 2011 at 8:13 pm By:
Arthritis OW OW Health and Active Health Library
FDA accepts application for Pfizer arthritis drug: Drugmaker Pfizer Inc. says the Food and Drug Administration h... http://t.co/O9hWize9
Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis - News Press Release | PharmiWeb.com
pharmiweb.com — “Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis - News Press Release | PharmiWeb.com” View full resource at pharmiweb.com
Most Recently Shared on December 20, 2011 at 2:59 pm By:
Press Release: Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accep... http://t.co/humdK9Bx
Pfizer Says FDA Accepts For Review NDA For Tofacitinib For Rheumatoid Arthritis
nasdaq.com — “NASDAQ News: Pfizer Says FDA Accepts For Review NDA For Tofacitinib For Rheumatoid Arthritis” View full resource at nasdaq.com
Most Recently Shared on December 20, 2011 at 2:59 pm By:
Pfizer Says FDA Accepts For Review NDA For Tofacitinib For Rheumatoid Arthritis: Pfizer Says FDA Accepts For Rev... http://t.co/eYgysDq1
Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Pfizer Inc. announced today that the U.S. Food and Drug Administration has accepted for review the New Drug Application for tofacitinib , an investigational novel, oral JAK inhibitor being studied for the treatment of adult patients with moderately to severely active rheumatoid arthritis .” View full resource at finance.yahoo.com
Most Recently Shared on December 20, 2011 at 2:12 pm By:
Arthritis OW OW Health and Active Health Library
Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moder... http://t.co/ufC2Qxa6
FDA to review Pfizer rheumatoid arthritis drug - Yahoo! News
news.yahoo.com — “From Yahoo! News: (Reuters) - U.S. health regulators have accepted the application for Pfizer Inc's closely watched experimental rheumatoid arthritis drug, the drugmaker said on Tuesday. The Food and Drug Administration is due to decide on the drug, tofacitinib, in August. Pfizer said it has also submitted an application for tofacitinib to regulatory authorities in Japan. Tofacitinib is one of Pfizer's most important experimental drugs. An oral medicine, it could provide a more convenient altern” View full resource at news.yahoo.com
Most Recently Shared on December 20, 2011 at 2:12 pm By:
Arthritis OW OW Health and Active Health Library
FDA to review Pfizer rheumatoid arthritis drug: (Reuters) - U.S. health regulators have accepted the application... http://t.co/3CMNzUTG
Pfizer RA Drug Meets Goals of Trial, Company Optimistic for FDA Approval - AOL Health
aolhealth.com — “Pfizer Inc is hoping to release its experimental rheumatoid arthritis drug after successfully completing another stage of a clinical trial. The trial” View full resource at aolhealth.com
Most Recently Shared on March 7, 2011 at 10:00 pm By:
#Pfizer Inc is hoping to release its experimental rheumatoid #arthritis drug after completing another stage of a trial.http://aol.it/gUwxqT
FDA accepts NDA for Vimovo for treatment of arthritis and ankylosing spondylitis - MPR
empr.com — “Pozen announced that a New Drug Application (NDA) for Vimovo (formerly PN 400), a fixed-dose combination tablet containing enteric-coated naproxen and immediate-release esomeprazole, has been filed and accepted for review by the FDA for the treatment of the signs and symptoms of osteoarthritis (OA), rheumatoid arthritis (RA), and ankylosing spondylitis (AS) in patients who are at risk of developing non-steroidal anti-inflammatory drug (NSAID) associated gastric ulcers.” View full resource at empr.com
Most Recently Shared on August 31, 2009 at 6:24 pm By:
MPR News: FDA accepts NDA for Vimovo for treatment of arthritis and ankylosing spondylitis: Pozen annou.. http://bit.ly/1cBz3g
Advertisement
